Registry of cancer patients treated with hyperthermia
Prospektive Hyperthermie-Datenbank Bei Krebspatienten (HTRegister)
This study is collecting information from cancer patients treated with heat therapy to see how well it works alongside regular treatments and how it affects their health and survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Berlin and 1 other locations) |
| Trial ID | NCT05993910 on ClinicalTrials.gov |
What this trial studies
This observational registry collects data on cancer patients at Charité who are treated with hyperthermia alongside standard oncological therapies. The study aims to evaluate the therapeutic use of hyperthermia, tracking patient outcomes such as complications, disease status, and survival rates. Additionally, patients may participate in translational research to identify prognostic factors related to their response to hyperthermia treatment. A total of 1000 patients will be included in this registry to provide comprehensive insights into the effectiveness and safety of hyperthermia in cancer care.
Who should consider this trial
Good fit: Ideal candidates include cancer patients who are receiving hyperthermia as part of their treatment regimen.
Not a fit: Patients with contraindications to hyperthermia, such as certain metal implants or mental health conditions that impair study participation, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of hyperthermia's role in cancer treatment, potentially improving patient outcomes.
How similar studies have performed: While the use of hyperthermia in cancer treatment has been explored, this registry approach is relatively novel and aims to systematically document outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Contrazeption with female patients at the capable of bearing children age * Written agreement is present (DvH, ICH-GCP) * Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion for the interventional study represents. * With children must the treatment with one of the GPOH agreed Pattern take place Exclusion Criteria: * Exclusion criteria for the hyperthermia (such as hip prosthesis in the therapeutic area, metal implants/marker, patients with cardiac pacemakers) * mental disease, what the proper study participation does not allow.
Where this trial is running
Berlin and 1 other locations
- Clinic for Radio - Oncology and Radiotherapy — Berlin, Germany (Not_yet_recruiting)
- Clinic for Radio - Oncology and Radiotherapy — Berlin, Germany (Recruiting)
Study contacts
- Study coordinator: Pirus Ghadjar, PD Dr.
- Email: pirus.ghadjar@charite.de
- Phone: +4930450657055
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.